JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.21B |
| 2 |
Microsoft
MSFT
|
+$2.18B |
| 3 |
Tesla
TSLA
|
+$1.1B |
| 4 |
NXP Semiconductors
NXPI
|
+$1.04B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$998M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.32B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 4 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.31B |
| 5 |
PayPal
PYPL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.77% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.83% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4926
Dutch Bros
BROS
$9.12B
| $308K | ﹤0.01% |
+6,043
| New | +$335K |
|
4927
Village Super Market
VLGEA
$631M
| $308K | ﹤0.01% |
13,209
+5,761
| +77% | +$129K |
|
|
AFMD
4928
DELISTED
Affimed
AFMD
| $307K | ﹤0.01% |
5,560
+419
| +8% | +$25.9K |
|
4929
Star Bulk Carriers
SBLK
$3.23B
| $307K | ﹤0.01% |
13,585
-169,899
| -93% | -$3.57M |
|
4930
Smith Micro Software
SMSI
$15.6M
| $307K | ﹤0.01% |
1,564
+1,120
| +252% | +$245K |
|
4931
BlackRock Science and Technology Trust
BST
$1.73B
| $306K | ﹤0.01% |
6,121
+1,121
| +22% | +$58.7K |
|
|
EBET
4932
DELISTED
EBET, INC. Common Stock
EBET
| $306K | ﹤0.01% |
496
+272
| +121% | +$208K |
|
4933
Cytosorbents Corp
CTSO
$24.2M
| $304K | ﹤0.01% |
72,386
+56,784
| +364% | +$319K |
|
4934
Gaotu Techedu
GOTU
$403M
| $304K | ﹤0.01% |
156,495
-1,626,359
| -91% | -$4.54M |
|
|
RBOT
4935
DELISTED
Vicarious Surgical
RBOT
| $304K | ﹤0.01% |
+955
| New | +$337K |
|
|
BIOC
4936
DELISTED
Biocept, Inc.
BIOC
| $303K | ﹤0.01% |
2,793
+2,273
| +437% | +$262K |
|
4937
Thryv Holdings
THRY
$95.1M
| $302K | ﹤0.01% |
7,344
+2,523
| +52% | +$86.9K |
|
|
VBNK
4938
VersaBank
VBNK
$654M
| $302K | ﹤0.01% |
25,400
-600
| -2% | -$7.29K |
|
4939
Information Services Group
III
$251M
| $301K | ﹤0.01% |
39,566
+9,796
| +33% | +$78.9K |
|
4940
Enact Holdings
ACT
$6.87B
| $300K | ﹤0.01% |
+14,492
| New | +$314K |
|
4941
Seres Therapeutics
MCRB
$45.2M
| $300K | ﹤0.01% |
1,793
-28,479
| -94% | -$4.53M |
|
|
VRAY
4942
DELISTED
ViewRay, Inc.
VRAY
| $300K | ﹤0.01% |
54,501
+2,506
| +5% | +$15.3K |
|
4943
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.21B
| $298K | ﹤0.01% |
5,818
-1,172
| -17% | -$58.5K |
|
4944
MBIA
MBI
$261M
| $297K | ﹤0.01% |
18,854
+972
| +5% | +$12.8K |
|
|
VXRT
4945
DELISTED
Vaxart
VXRT
| $297K | ﹤0.01% |
47,352
+2,043
| +5% | +$13.9K |
|
|
CRHC
4946
CALL
DELISTED
Cohn Robbins Holdings Corp.
CRHC
| $297K | ﹤0.01% |
+30,200
| New | +$298K |
|
|
MYOV
4947
CALL
DELISTED
Myovant Sciences Ltd.
MYOV
| $296K | ﹤0.01% |
+19,000
| New | +$363K |
|
4948
BioAtla
BCAB
$5.14M
| $295K | ﹤0.01% |
300
-230
| -43% | -$294K |
|
4949
Amplify Alternative Harvest ETF
MJ
$112M
| $295K | ﹤0.01% |
2,222
+233
| +12% | +$36.7K |
|
4950
JPMorgan US Quality Factor ETF
JQUA
$8.63B
| $294K | ﹤0.01% |
6,462
| – | – |
|
Similar funds
JP Morgan Chase's Q4 2021 Portfolio in Review
As of Q4 2021, JP Morgan Chase held 7,322 positions worth $866B, up 7.1% from $809B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2021 filing shows 665 new, 2,967 increased, 2,175 reduced and 543 closed positions. Its largest new stake was Rivian: 4,642,731 shares worth $481M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $4.32B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2021 buy was Rivian: 4,642,731 shares worth $481M.
- JP Morgan Chase added most to Amazon in Q4 2021, an estimated $2.21B increase.
- JP Morgan Chase's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.32B.
- JP Morgan Chase fully exited Kansas City Southern in Q4 2021, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 17% of its $866B portfolio in Q4 2021.
- JP Morgan Chase opened 665 new positions and closed 543 in Q4 2021.
- JP Morgan Chase's portfolio value rose 7.1% quarter-over-quarter to $866B.
Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.